Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.

ABSTRACT:

Opinion statement

As the field of oncology enters the era of precision medicine and targeted therapies, we have come to realize that there may be no single "magic bullet" for patients with head and neck cancer. While immune check point inhibitors and some targeted therapeutics have shown great promise in improving oncologic outcomes, the current standard of care in most patients with head and neck squamous cell carcinoma (HNSCC) remains a combination of surgery, radiation, and/or cytotoxic chemotherapy. Nevertheless, advances in precision medicine, next-generation sequencing (NGS), and targeted therapies have a potential future in the treatment of HNSCC. These roles include increased patient treatment stratification based on predictive biomarkers or targetable mutations and novel c

SUBMITTER: Solis RN 

PROVIDER: S-EPMC9196261 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature